Scientists have found that drugs designed to quit smoking do not increase the likelihood of developing cardiovascular complications, according to Pannochka, an online publication for girls and women aged 14 to 35.. net The study included 8,058 people who were followed up for 28 weeks. Before that, they went through a double-blind, randomized and placebo-controlled study, which was conducted in 140 different centers.. The subjects were exclusively smokers who were given one of three popular anti-smoking drugs such as varenicline, bupropion hydrochloride, or nicotine replacement therapy in the form of nicotine patches..

The dosage of the first drug was 1 mg twice a day, the second 150 mg also twice a day, and the test subject glued the patch with 21 mg of the substance every day.. The main objective of the study was to compare the safety of the use of the above drugs with each other and to check their effect on cardiovascular complications in comparison with the placebo group..

At the end of the study, it turned out that all three groups had almost the same number of complications of this kind and they were very low.. Psychiatric illnesses of some participants did not affect the result in any way.

aspect. net.